Categories AlphaGraphs, Earnings, Health Care
PFE Earnings: All you need to know about Pfizer’s Q2 2023 earnings results
Pfizer Inc. (NYSE: PFE) reported second quarter 2023 earnings results today.
Revenues decreased 54% year-over-year to $12.7 billion.
![](https://cdn.news.alphastreet.com/wp-content/uploads/2023/08/Pfizer-Q2-2023-Earnings-Infographic-648x1024.jpg)
Reported net income declined 77% to $2.3 billion, or $0.41 per share, compared to last year. Adjusted EPS fell 67% to $0.67.
While earnings beat expectations, revenue fell short of estimates.
For the full year of 2023, revenues are expected to range between $67-70 billion while adjusted EPS is estimated to range between $3.25-3.45.
The stock dropped 1% in premarket hours on Tuesday following the report.
Prior performance
![](https://cdn.news.alphastreet.com/wp-content/uploads/2023/05/Pfizer-Q1-2023-Earnings-Infographic-1-648x1024.jpg)
Most Popular
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q2 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported its second quarter 2024 earnings results today. Net sales increased 4.9% year-over-year to $5 billion. Organic sales increased 9%. Net income attributable to Colgate-Palmolive Company was $731
Key takeaways from Visa’s Q3 2024 earnings report
Credit card behemoth Visa, Inc. (NYSE: V) this week reported mixed results for the June quarter, with earnings matching expectations and sales slightly missing the view. Both numbers grew in
Southwest Airlines (LUV): A look at the airline’s performance in Q2 2024
Shares of Southwest Airlines Co. (NYSE: LUV) were up over 6% on Thursday after the company beat earnings estimates for the second quarter of 2024. The stock has gained 4%